These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
607 related items for PubMed ID: 29596472
1. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine. Hachiya M, Miyano S, Mori Y, Vynnycky E, Keungsaneth P, Vongphrachanh P, Xeuatvongsa A, Sisouk T, Som-Oulay V, Khamphaphongphane B, Sengkeopaseuth B, Pathammavong C, Phounphenghak K, Kitamura T, Takeda M, Komase K. PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472 [Abstract] [Full Text] [Related]
2. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling. Hachiya M, Vynnycky E, Mori Y, Do HT, Huynh MK, Trinh LH, Nguyen DD, Tran NAT, Hoang TT, Hoang HHT, Vo NDT, Le TH, Ichimura Y, Miyano S, Okawa S, Thandar MM, Yokobori Y, Inoue Y, Mizoue T, Takeda M, Komada K. Int J Infect Dis; 2024 Jul; 144():107053. PubMed ID: 38641317 [Abstract] [Full Text] [Related]
3. Estimating the immunogenicity of measles-rubella vaccination administered during a mass campaign in Lao People's Democratic Republic using multi-valent seroprevalence data. Vynnycky E, Miyano S, Komase K, Mori Y, Takeda M, Kitamura T, Xeuatvongsa A, Hachiya M. Sci Rep; 2019 Aug 29; 9(1):12545. PubMed ID: 31467441 [Abstract] [Full Text] [Related]
4. Comparison of population-based measles-rubella immunoglobulin G antibody prevalence between 2014 and 2019 in Lao People's Democratic Republic: Impacts of the national immunization program. Miyano S, Vynnycky E, Pattamavone C, Ichimura Y, Mori Y, Nouanthong P, Phounphenghack K, Tengbriacheu C, Khamphaphongphane B, Franzel L, Yang TU, Raaijimarkers H, Komada K, Ota T, Funato M, Takeda M, Hachiya M. Int J Infect Dis; 2023 Apr 29; 129():70-77. PubMed ID: 36758852 [Abstract] [Full Text] [Related]
5. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey. Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, Phiri C, Book C, Thuma PE, Moss WJ. Vaccine; 2019 Apr 17; 37(17):2387-2393. PubMed ID: 30905529 [Abstract] [Full Text] [Related]
6. Measles and rubella immunity in the population of Bhutan, 2017. Wangchuk S, Nogareda F, Tshering N, Khandu L, Pelden S, Wannemuehler K, Wangdi S, Wangchuk U, Mulders M, Tamang T, Patel MK. Vaccine; 2019 Oct 08; 37(43):6463-6469. PubMed ID: 31500970 [Abstract] [Full Text] [Related]
7. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020. Murhekar MV, Gupta N, Hasan AZ, Kumar MS, Kumar VS, Prosperi C, Sapkal GN, Thangaraj JWV, Kaduskar O, Bhatt V, Deshpande GR, Thankappan UP, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sharma S, Sarmah NP, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Shrivastava AK, Chonker SK, Tilekar B, Tandale BV, Ahmad M, Sangal L, Winter A, Mehendale SM, Moss WJ, Hayford K. Lancet Glob Health; 2022 Nov 08; 10(11):e1655-e1664. PubMed ID: 36240831 [Abstract] [Full Text] [Related]
8. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination. Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S616-21. PubMed ID: 21954256 [Abstract] [Full Text] [Related]
9. Seroprevalence of measles and rubella antibodies in vaccinated and unvaccinated infants in the Lao People's Democratic Republic. Hefele L, Xaydalasouk K, Kleine D, Homsana A, Xayavong D, Syphan S, Hübschen JM, Muller CP, Black AP. Int J Infect Dis; 2021 Jul 01; 108():524-530. PubMed ID: 34119678 [Abstract] [Full Text] [Related]
10. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination. Tohme RA, François J, Wannemuehler K, Magloire R, Danovaro-Holliday MC, Flannery B, Cavallaro KF, Fitter DL, Purcell N, Dismer A, Tappero JW, Vertefeuille JF, Hyde TB. Trop Med Int Health; 2014 Sep 01; 19(9):1105-15. PubMed ID: 25041586 [Abstract] [Full Text] [Related]
11. Age-stratified seroprevalence of vaccine-preventable infectious disease in Saravan, Southern Lao People's Democratic Republic. Xaydalasouk K, Sayasinh K, Hübschen JM, Khounvisith V, Keomany S, Muller CP, Black AP. Int J Infect Dis; 2021 Jun 01; 107():25-30. PubMed ID: 33864919 [Abstract] [Full Text] [Related]
12. The determinants of immunization coverage among children aged between 12 and 35 months: a nationwide cross-sectional study in Lao People's Democratic Republic. Ichimura Y, Yanagisawa N, Thandar MM, Pathammavong C, Phounphenghuk K, Nouanthong P, Tengbriacheu C, Khamphaphongphane B, Franzel-Sassanpour LE, Yang TU, Raaijmakers H, Ota T, Komada K, Hachiya M, Miyano S. BMC Public Health; 2022 Dec 03; 22(1):2259. PubMed ID: 36463130 [Abstract] [Full Text] [Related]
13. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran. Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J. Int J Infect Dis; 2008 Jan 03; 12(1):43-6. PubMed ID: 17950020 [Abstract] [Full Text] [Related]
14. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K, Nicoara C, Germann D, Matter L. Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837 [Abstract] [Full Text] [Related]
15. Progress in measles and rubella elimination in Iran. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F. Pediatr Infect Dis J; 2007 Dec 25; 26(12):1137-41. PubMed ID: 18043452 [Abstract] [Full Text] [Related]
16. Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022. Shanmugasundaram D, Viswanathan R, Winter AK, Agarwal A, Roychowdhury B, Muliyil D, Prasad GRV, Pushpalatha K, Gowda M, Singh P, Priyasree J, Bonu R, Jha S, Kumar Jena S, Jain S, Suri V, Hebbale V, Jain A, Mary Abraham A, Mishra B, Kumar Pati B, Biswas D, Pratkeye D, Ashok M, Singh MP, Dhodapkar R, Ray R, Gadepalli R, Ratho RK, Rani S, Shukla S, Ali A S, Lakshmi Nag V, Sabarinathan R, Saravana Kumar V, Priya R P, Dwibedi B, Sapkal G, Singh H, Singh K, Tiwari L, Jain M, Mondal N, Sreenivasan P, Mahantesh S, Verma S, Awasthi S, Malik S, Santhanam S, Datta S, Kumar A, Kant Chowdhary B, Khera D, Jain M, Kumar P, Pati S, Tripathi S, Murhekar M. Vaccine; 2024 Oct 24; 42(24):126077. PubMed ID: 38960788 [Abstract] [Full Text] [Related]
17. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey. Kriss JL, Grant GB, Moss WJ, Durrheim DN, Shefer A, Rota PA, Omer SB, Masresha BG, Mulders MN, Hanson M, Linkins RW, Goodson JL. Vaccine; 2019 Sep 10; 37(38):5745-5753. PubMed ID: 30898393 [Abstract] [Full Text] [Related]